This poster presentation will reflect background information showing that, according to the (NSCISC) National Spinal Cord Injury Statistical Center, there are approximately 12,000 new spinal cord injuries (SCI) each year. In 2007, there were approximately 255,702 persons in the U.S. living with a SCI (spinal cord injury); and nearly one-half have tetraplegia (paralysis of both upper and lower extremities), with 40% of these relying on mechanical ventilation. Respiratory diseases are the third most common source of re-hospitalization, prolong acute care length of stay, and delay rehabilitation. 

Published data shows the relationship between hours on a mechanical ventilator and incidence of VAP (ventilator acquired pneumonia). The average cost of a single VAP is estimated at $40,000. The purpose of this presentation is to examine the financial, medical, and quality of life costs of high spinal cord injuries; and to explore available respiratory management options.

Method:

Since the 1970’s, positive-pressure mechanical ventilation has been the primary mechanism for treating respiratory insufficiency in individuals with high spinal cord injuries. While mechanical ventilation is life-preserving, it is not without limitations and complications. Research into alternative technology for treating chronic respiratory insufficiency led to the development of devices that cause the diaphragm to contract via neurostimulation of the phrenic nerve or the diaphragm itself. Individuals, once dependent on mechanical ventilation, now breathe free of the ventilator from 4-24 hours a day. Health care teams assist individuals in life-long care planning and the transition from a long-term care facility to a home environment.

Results:

A case study will illustrate the impact of the implantation of a diaphragm stimulator device on an individual with a high spinal cord injury, his family, and the health care community as a whole.

Conclusion: